Markus Enzelberger

Markus Enzelberger is currently a Partner at Versant Ventures and an Entrepreneur in Residence involved in launching future newcos from Versant's Ridgeline Discovery Engine. Markus also holds board member positions at Matterhorn Biosciences, Granite Bio, Vector BioPharma, Ridgeline Discovery, and Cimeio Therapeutics. In addition, Markus serves as a Senior Advisor at SHS Capital and a Board Observer at T-knife. With a background in Applied Physics and Chemie, Markus Enzelberger has a wealth of experience in the bioscience industry.